Joseph W. Poitier Jr.

Joseph Poitier practices at Quiet Minds Incorporated in North Miami, Florida.

Joseph Poitier's NPI, 1003038738, was assigned on May 3, 2007. Joseph Poitier graduated from University of Miami, Miller School of Medicine in 1980. Joseph Poitier holds Florida license ME38778.

Joseph Poitier's primary practice is Quiet Minds Incorporated, at 12955 Biscayne Blvd, North Miami, FL 33181 in Miami-Dade County. The practice phone is (305) 895-3231.

Joseph Poitier's primary practice is Quiet Minds Incorporated in North Miami, Florida. The medical group on file is Quiet Minds Inc. Dmand AI also links Joseph Poitier to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joseph Poitier practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Joseph Poitier's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Joseph Poitier is board certified in psychiatry by the American Board of Psychiatry and Neurology. Joseph Poitier is licensed in Florida.

Dmand AI lists ADHD, alcohol use disorders, anxiety, bipolar disorder, depression and schizophrenia among the conditions Joseph Poitier treats.

CMS data shows 691 Medicare services from Joseph Poitier across 4 procedure codes in 2024, for 168 Medicare patients. Medicare paid $46,289 for them.

CMS counts 168 Medicare patients who saw Joseph Poitier in 2024. The largest group is under 65, with 100 patients. 60% of them have mood disorders, and 54% have high blood pressure. 78% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Joseph Poitier's median patient age at 56, with 57% women.

In 2024, Joseph Poitier wrote 3,606 Medicare Part D claims for 395 patients. 95% of them were for generic drugs. CMS names the drug for 3,470 of them, across 40 drugs with 11 or more claims each, at $206,399 in total drug cost. In 2023, CMS named 3,899 claims across 42 drugs.

Joseph Poitier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Joseph Poitier as offering telehealth.

Dmand AI links Joseph Poitier to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 285 general payments to Joseph Poitier from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $991.

Joseph Poitier graduated from University of Miami, Miller School of Medicine in 1980.

Joseph Poitier is in network with 15 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.